Global Oncology Informatics Market

Report ID : 1032 | Published : 2021-07-16 | Pages: 140 | Format: PDF/EXCEL

Oncology informatics plays a vital role in cancer research and treatment. Different resources, methods, and devices/tools are used in this field to deal with cancer. Oncology informatics is very useful in the process of drug discovery and development. The oncology informatics market is growing due to an increasing number of cancer patients and the rise in the adoption of advanced technologies.
There are multiple factors that drive the oncology informatics market, such as the high prevalence of cancer, rising adoption of advanced technologies (EHRs), medical errors reduction in cancer care, the rising cost of cancer care, various government initiatives for the cancer therapy developments and increase in the awareness of the different types of oncology treatments. However, factors such as the high cost of tools, shortage of medical oncologists, data security concerns, and complex and time-consuming therapy procedures can downscale the growth of the oncology informatics market over the forecast period 2020-2030.


The oncology informatics market has been segmented into Types, End-users, and Regions. The Types segment comprises Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support Systems (CDSS), Drug Discovery and Development Informatics, and Image Analytics. EHR is expected to dominate the market during the forecast period. Oncology image analytics solutions are also expected to grow at the highest CAGR during the forecast period. By End-users, the market is divided into Pharmaceutical Industry, Life Science Industry, Contract Research Organizations (CROs), Academic Institutes and Research Centers, and Others (Hospitals and Other Care Facilities). In terms of revenue, pharmaceutical Industries and life science industries are the major end-users segments of the oncology informatics market. At the regional level, the oncology informatics market can be segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to be the significant market shareholder of this market, followed by Asia-Pacific, Europe, and Rest-of-the-World.
Some of the key Players of oncology informatics market are Cerner Corporation, Change Healthcare, Elekta AB, F. Hoffmann-La Roche Ltd, Hologic, Inc., IBM Corporation, Inspirata, Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc., Oncology Analytics, Inc, PerkinElmer, Inc., RELX Group, Sirenas, LLC, UnitedHealth Group, Inc, Varian, Medical Systems, Inc, and other Prominent Players.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Oncology Informatics Market Snapshot

Chapter 4. Global Oncology Informatics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. COVID 19 Impact Analysis

4.7. Major Investment, Partnerships and Collaborations in Oncology Research

Chapter 5. Market Segmentation 1: By Types Estimates & Trend Analysis

5.1. By Types & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Types:

5.2.1. Electronic Health Records (EHRs)

5.2.2. Population Health Management (PHM)

5.2.3. Clinical Decision Support System (CDSS)

5.2.4. Drug Discovery and Development Informatics

5.2.5. Image Analytics

Chapter 6. Market Segmentation 2: By End-Users Estimates & Trend Analysis

6.1. By End-Users & Market Share, 2020& 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:

6.2.1. Pharmaceutical Industry

6.2.2. Life Science Industry

6.2.3. Contract Research Organizations (CROs)

6.2.4. Academic Institutes and Research Centers

6.2.5. Others (Hospitals and Other Care Facilities)

Chapter 7. Oncology Informatics Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Oncology Informatics Market revenue (US$ Million) estimates and forecasts By Types, 2020-2030

7.1.2. North America Oncology Informatics Market revenue (US$ Million) estimates and forecasts By End-Users, 2020-2030

7.1.3. North America Oncology Informatics Market revenue (US$ Million) estimates and forecasts by country, 2020-2030 

7.2. Europe

7.2.1. Europe Oncology Informatics Market revenue (US$ Million) By Types, 2020-2030

7.2.2. Europe Oncology Informatics Market revenue (US$ Million) By End-Users, 2020-2030

7.2.3. Europe Oncology Informatics Market revenue (US$ Million) by country, 2020-2030

7.3. Asia Pacific

7.3.1. Asia Pacific Oncology Informatics Market revenue (US$ Million) By Types, 2020-2030

7.3.2. Asia Pacific Oncology Informatics Market revenue (US$ Million) By End-Users, 2020-2030

7.3.3. Asia Pacific Oncology Informatics Market revenue (US$ Million) by country, 2020-2030

7.4. Latin America

7.4.1. Latin America Oncology Informatics Market revenue (US$ Million) By Types, (US$ Million)

7.4.2. Latin America Oncology Informatics Market revenue (US$ Million) By End-Users, (US$ Million)

7.4.3. Latin America Oncology Informatics Market revenue (US$ Million) by country, (US$ Million) 2020-2030

7.5. Middle East & Africa

7.5.1. Middle East & Africa Oncology Informatics Market revenue (US$ Million) By Types, (US$ Million)

7.5.2. Middle East & Africa Oncology Informatics Market revenue (US$ Million) By End-Users, (US$ Million)

7.5.3. Middle East & Africa Oncology Informatics Market revenue (US$ Million) by country, (US$ Million) 2020-2030

Chapter 8. Competitive Landscape

8.1. Company Profiles

8.1.1. Cerner Corporation

8.1.2. Change Healthcare

8.1.3. Elekta AB

8.1.4. F. Hoffmann-La Roche Ltd

8.1.5. Hologic, Inc.

8.1.6. IBM Corporation

8.1.7. Inspirata, Inc.

8.1.8. Koninklijke Philips N.V.

8.1.9. Laboratory Corporation of America Holdings

8.1.10. McKesson Corporation

8.1.11. MIM Software, Inc.

8.1.12. Oncology Analytics, Inc

8.1.13. PerkinElmer, Inc.

8.1.14. RELX Group

8.1.15. Sirenas, LLC

8.1.16. UnitedHealth Group, Inc

8.1.17. Varian Medical Systems, Inc

8.1.18. DOSIsoft SA

8.1.19. ViewRay Inc.

8.1.20. Prowess, Inc.

8.1.21. Flatiron Health

8.1.22. RaySearch Laboratories

8.1.23. Other Prominent Player

Global Oncology Informatics Market Segmentation

Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Types

  • Electronic Health Records (EHRs)
  • Population Health Management (PHM)
  • Clinical Decision Support System (CDSS)
  • Drug Discovery and Development Informatics
  • Image Analytics

Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on End-users

  • Pharmaceutical Industry
  • Life Science Industry
  • Contract Research Organizations (CROs)
  • Academic Institutes and Research Centers
  • Others (Hospitals and Other Care Facilities)

Global Oncology Informatics Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 Based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Oncology Informatics Market Revenue (US$ Million) By Country, 2019 To 2030

  • U.S.
  • Canada

Europe Oncology Informatics Market Revenue (US$ Million) By Country, 2019 To 2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Oncology Informatics Market Revenue (US$ Million) By Country, 2019 To 2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Oncology Informatics Market Revenue (US$ Million) By Country, 2019 To 2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Oncology Informatics Market Revenue (US$ Million) By Country, 2019 To 2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients